Delivery Order SPE2DB22D9316-SPE2DB25FYP97
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $13,389.36 to DMS Pharmaceutical Group Inc. for the supply of Nplate 250 microgram vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this order at its facility in Park Ridge, IL, with an ultimate completion date of August 11, 2025. The award was issued on July 21, 2025, and does not include a set-aside designation, allowing the...
- The Defense Logistics Agency awarded a delivery order valued at $6,697.06 to DMS Pharmaceutical Group Inc. for the supply of Nplate 500 microgram vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform work at its Park Ridge facility with an ultimate completion date of August 14, 2025. This delivery order utilizes a firm fixed-price contract type with no set-aside designation, allowing the company to compete on a...
- The Defense Logistics Agency issued a firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 250 microgram vials of Nplate, valued at $8,368.35, with an ultimate completion date of September 12, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The company will perform the work at its Park Ridge location and deliver the pharmaceutical product to support federal...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,347.34 by the Defense Logistics Agency on July 31, 2025, for the supply of Nplate 250 microgram vials. The delivery order carries an ultimate completion date of August 21, 2025, and requires performance at the contractor's Park Ridge, Illinois facility. This award was issued without a set-aside designation, allowing DMS...
- The Defense Logistics Agency awarded a delivery order valued at $1,673.67 to DMS Pharmaceutical Group Inc. for the supply of Nplate 250 microgram vials. This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, represents a pharmaceutical supply requirement to support Department of Defense healthcare operations. The award was made without a set-aside designation, and the products will be delivered to Park Ridge, Illinois, where the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,697.06 by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Nplate 500 microgram vials. This firm fixed-price delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,366.20 by the Defense Logistics Agency on September 2, 2025, for the supply of Nplate 125 microgram vials. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and extending through November 2026. The...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $8,472.80, is for the delivery of Nplate 250 mcg vials. It has an ultimate completion date of November 29, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of pharmaceutical products...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,167.36 contract is for the supply of Nplate 250 mcg vials, with a period of performance ending on October 15, 2024. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program....
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of NPLATE 250 MCG VIALS. The contract, valued at $10,167.36, has an ultimate completion date of June 20, 2024 and was awarded on May 29, 2024. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of pharmaceutical products and medical supplies to the U.S. federal...
- SPE2DB22D9316Indefinite Delivery Contract
- SPE2DB22D9316-SPE2DB25FYP97Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $21,681.63 to DMS Pharmaceutical Group Inc. for the supply of Nplate 250 microgram vials. The award, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, utilizes a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its location in Park Ridge. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 through November 2026. The larger IDC vehicle enables DLA to procure a comprehensive range of pharmaceutical products supporting military health facility requirements nationwide. Nplate (romiplostim), an important therapeutic agent used in treating thrombocytopenia, represents one of the specialized pharmaceutical products available through this arrangement. As an established federal supplier with consistent contract performance across diverse pharmaceutical categories, DMS Pharmaceutical Group serves as a critical distribution channel for prescription drugs, biologics, and medical consumables to Department of Defense healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.7k | 9/2/25 |